Squarepoint Ops LLC Adverum Biotechnologies, Inc. Transaction History

Squarepoint Ops LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.26 $31,750 - $53,340	42,334 New	42,334 $31,000
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $18,528 - $29,374	-15,064 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $32,644 - $45,026	-18,761 Reduced 55.46%	15,064 $27,000
Q3 2021 Nov 15, 2021	BUY	$2.08 - $3.6 $14,597 - $25,264	7,018 Added 26.18%	33,825 $73,000
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $90,071 - $283,081	26,807 New	26,807 $94,000
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $239,083 - $370,760	-25,819 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $651,585 - $944,268	-66,218 Reduced 71.95%	25,819 $280,000
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $947,981 - $1.99 Million	92,037 New	92,037 $948,000
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $893,528 - $1.83 Million	-111,971 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $454,128 - $1.08 Million	-88,697 Reduced 44.2%	111,971 $1.29 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $978,140 - $2.97 Million	186,668 Added 1333.34%	200,668 $1.09 Million
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $71,400 - $166,460	14,000 New	14,000 $166,000
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $157,102 - $204,529	-29,642 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $108,193 - $235,653	29,642 New	29,642 $172,000
Q4 2017 Feb 14, 2018	SELL	$2.85 - $3.95 $90,630 - $125,610	-31,800 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $77,910 - $116,070	31,800	31,800 $116,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.